9. How I have changed my practice following new guidelines

Update: 2020-11-25

Description

Clinical practice in type 2 diabetes has changed, learn more from Professor Abrahamson.
Learning objective: Following this activity, you will be able to more confidently tailor treatments for people with T2DM, particularly newer agents

Comments

In Channel

1. When and how to initiate insulin

2020-11-2607:17

2. How to support people earlier in living with diabetes

2020-11-2609:12

3. Sulphonylureas and managing hypoglycaemia in practice

2020-11-2609:53

4. Why should I treat more intensively earlier?

2020-11-2606:12

5. Can GLP-1 receptor agonists and SGLT-2 inhibitors be used together?

2020-11-2508:56

6. The key role of primary care in type 2 diabetes

2020-11-2505:30

7. An exciting time ahead for primary care physicians in diabetes

2020-11-2503:56

8. Discussing injectables with people living with diabetes

2020-11-2508:43

9. How I have changed my practice following new guidelines

2020-11-2508:22

10. Which people with type 2 diabetes would benefit from SGLT-2 inhibitors and GLP-1 receptor agonists?

2020-11-2511:04

11. Improving quality of life and confidence with continuous glucose monitoring

2020-11-2505:40

00:00

1.0x

9. How I have changed my practice following new guidelines

#box-pro-ellipsis-17661197739250{-webkit-line-clamp:2;}9. How I have changed my practice following new guidelines

9. How I have changed my practice following new guidelines

Ascend Diabetes

9. How I have changed my practice following new guidelines